
ZAP, LiGHT & SALT - American Academy of Ophthalmology
2020年4月1日 · ZAP: Prophylactic LPI for Primary Angle-Closure Suspects In the early 1900s, researchers found that an iridectomy could relieve acute attacks of high pressure in eyes of patients with narrow-angle glaucoma, said David S. Friedman, MD, PhD, MPH, at Harvard Medical School in Boston.
Laser peripheral iridotomy for the prevention of angle closure: a ...
2019年4月20日 · At the 72-month visit, laser peripheral iridotomy-treated eyes had a small but statistically significant benefit, with incidence of primary angle-closure disease in treated eyes of 4·2 cases per 1000 eye-years compared with 8·0 per 1000 eye-years in untreated eyes (hazard ratio 0·53, 95% CI 0·30–0·92).
Fourteen-Year Outcome of Angle-Closure Prevention with Laser …
2022年12月22日 · The Zhongshan Angle-Closure Prevention (ZAP) Study is a randomized controlled trial that enrolled 889 participants with bilateral PACS from Guangzhou, China.
Infographic: Zhongshan Angle Closure Prevention (ZAP) trial | Eye …
2021年5月10日 · The Zhongshan Angle Closure Prevention (ZAP) trial showed a low incidence rate of angle closure disease in angle closure suspects at 6 years and that...
ZAP: Prophylactic LPI for Primary Angle-Closure Suspects In the early 1900s, researchers found that an iridectomy could relieve acute attacks of high pressure in eyes of patients with narrow-angle glaucoma, said David S.
Can we zap eye floaters away? - Harvard Health
2017年8月8日 · Until we have better evidence for YAG vitreolysis — and Dr. Shah says several new clinical trials are underway — there are only two treatment options for floaters. One is a vitrectomy — surgical removal of the gel and the floaters from the back of the eye.
Design and methodology of a randomized controlled trial of …
The ZAP trial will determine if LI is safe and effective at preventing pathological angle closure in asymptomatic eyes with narrow angle configurations on gonioscopy. It will also provide data on what happens to untreated eyes in PACSs.
Infographic: Zhongshan Angle Closure Prevention (ZAP) trial
The Zhongshan Angle Closure Prevention (ZAP) trial showed a low incidence rate of angle closure disease in angle closure suspects at 6 years and that prophylactic peripheral iridotomy showed a modest effect in preventing angle closure disease.
Prevention of angle-closure glaucoma: balancing risk and benefit | Eye
2022年6月20日 · The Zhongshan Angle-closure Prophylaxis (ZAP) study provides the first clear insights into the natural history of PACS, and of the benefits of...
Evolution of Management on Primary Angle-Closure
2021年8月25日 · The ANA-LIS is significant not only because it confirms the findings from another landmark RCT on the management of PACS, the Zhongshan Angle Closure Prevention (ZAP) trial, but also because it provides a remarkable complement to the ZAP trial.